...
首页> 外文期刊>Annals of vascular surgery >Operative and 1-Year Outcomes of the Custom-Made Fenestrated Anaconda Aortic Stent Graft—A UK Multicenter Study
【24h】

Operative and 1-Year Outcomes of the Custom-Made Fenestrated Anaconda Aortic Stent Graft—A UK Multicenter Study

机译:手术和1年成果的定制陷阱蟒蛇主动脉支架移植物 - 英国多中心研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Early and 1-year outcomes are presented for fenestrated endovascular aneurysm repair (FEVAR) of complex aortic aneurysmal disease with the custom-made Anaconda fenestrated stent graft in 101 patients. Methods Retrospective site-reported data from the first 101 elective cases (20102014) from 4 UK centers were studied to evaluate patient demographics, aneurysm morphology, clinical success, and 1-year outcomes in patients undergoing fenestrated aneurysm repair with the custom-made Anaconda device. Results 101 fenestrated grafts (median age 76, 85% male) were implanted with a total of 255 fenestrations (196 renal arteries, 48 superior mesenteric artery, and 11 celiac arteries) with 3% mortality, 98.4% target vessel patency (TVP) at 30燿ay follow-up. Although 15 type I or III endoleaks were demonstrated at completion angiography, all 10 type Ia endoleaks resolved spontaneously. Survival by Kaplan-Meier analysis was 97% and 91% at 1 month and 1 year, respectively; with 75.8% showing reduction in abdominal aortic aneurysm diameter and only 1 patient with sac expansion. Freedom from loss of TVP was 97.6%. Conclusions Custom-made fenestrated Anaconda devices demonstrate low procedural mortality and a high rate of technical and clinical success at 30燿ays and 1 year.
机译:由于101名患者的定制的Anaconda脱嫩支架移植复杂主动脉瘤病患者的血管内血管内动脉瘤修复(FEVAR)提出了早期和1年的结果。方法研究来自4英国中心的前101个选修案例(20102014)的回顾性网站报告的数据来自4英国中心,以评估患者人口统计学,动脉瘤形态,临床成功和1年患者与定制的蟒蛇设备进行患者的患者。 。结果101植入植入移植(中位数76岁,85%男性)植入共有255名衰落(196动脉,48个优越的肠系膜动脉和11个乳糜泻),死亡率为3%,目标船舶通畅(TVP)为98.4% 30耀aysy后续行动。尽管在完成血管造影时证明了15型I型或III胚乳,但所有10型IA型胚胎都会自发地解决。 Kaplan-Meier分析的生存分别为97%,分别为97%和91%,分别为1个月和1年; 75.8%显示腹主动脉瘤直径减少,仅1例囊膨胀。免于TVP的自由为97.6%。结论定制的未结合的蟒蛇设备展示了低程序性死亡率和30‰Ays和1年的高级技术和临床成功率。

著录项

  • 来源
    《Annals of vascular surgery》 |2018年第2018期|共8页
  • 作者单位

    The Northern Vascular Centre Freeman Hospital Newcastle-upon-Tyne Hospitals NHS Trust;

    Department of Vascular Surgery and Interventional Radiology Royal Derby Hospital;

    Department of Vascular Surgery and Interventional Radiology Imperial College Healthcare NHS Trust;

    Department of Vascular Surgery and Interventional Radiology Frimley Park Hospital NHS Foundation;

    The Northern Vascular Centre Freeman Hospital Newcastle-upon-Tyne Hospitals NHS Trust;

    Department of Vascular Surgery and Interventional Radiology Imperial College Healthcare NHS Trust;

    Department of Vascular Surgery and Interventional Radiology Imperial College Healthcare NHS Trust;

    Department of Vascular Surgery and Interventional Radiology Frimley Park Hospital NHS Foundation;

    Department of Vascular Surgery and Interventional Radiology Royal Derby Hospital;

    The Northern Vascular Centre Freeman Hospital Newcastle-upon-Tyne Hospitals NHS Trust;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏血管和淋巴系外科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号